Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.16 USD | +2.65% | +2.65% | -16.55% |
13/06 | Enzo Biochem, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2024 | CI |
15/03 | North American Morning Briefing : Inflation Worries Continue to Weigh on Mood | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-16.55% | 5.97Cr | |
+40.80% | 5.37TCr | |
-8.05% | 3.88TCr | |
+35.79% | 3.89TCr | |
-8.98% | 2.73TCr | |
+10.69% | 2.59TCr | |
-16.21% | 2.03TCr | |
+31.00% | 1.28TCr | |
+28.51% | 1.22TCr | |
-1.67% | 1.2TCr |
- Stock Market
- Equities
- ENZ Stock
- News Enzo Biochem, Inc.
- Enzo Biochem to Sell Clinical Laboratory Division to Laboratory Corp. of America for $146 Million in Cash